Environmental and dietary risk factors in Alzheimer's disease
- PMID: 17610395
- DOI: 10.1586/14737175.7.7.887
Environmental and dietary risk factors in Alzheimer's disease
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease that affects millions in the aging population worldwide and will affect millions more in the next 20 years. Over 90% of all cases are sporadic, with genetics playing a minor role in the etiology of AD. Therefore, it is crucial to investigate the environment and diet as primary risk factors in AD pathology. This review considers epidemiologic case control studies, and in vitro and in vivo research to investigate the potential of environmental exposure to metals, air pollution and pesticides as well as diet as risk factors for AD. In some cases, the role of genetic mutations and environmental risk is discussed. The evidence examined in this review provides a brief overview of the current literature on selected, significant risk factors in promoting amyloid-beta accumulation and aggregation, thus contributing to neurodegeneration.
Similar articles
-
Environmental pesticide exposure as a risk factor for Alzheimer's disease: a case-control study.Environ Res. 2001 May;86(1):37-45. doi: 10.1006/enrs.2001.4254. Environ Res. 2001. PMID: 11386739
-
Molecular genetics of Alzheimer's disease: an update.Ann Med. 2008;40(8):562-83. doi: 10.1080/07853890802186905. Ann Med. 2008. PMID: 18608129 Review.
-
Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases.Mutat Res. 2009 Jul 10;667(1-2):82-97. doi: 10.1016/j.mrfmmm.2008.10.011. Epub 2008 Oct 31. Mutat Res. 2009. PMID: 19026668 Review.
-
Risk and protective factors for sporadic Alzheimer's disease.Acta Virol. 2007;51(4):205-22. Acta Virol. 2007. PMID: 18197729 Review.
-
Environmental-induced oxidative stress in neurodegenerative disorders and aging.Mutat Res. 2009 Mar 31;674(1-2):73-84. doi: 10.1016/j.mrgentox.2008.09.013. Epub 2008 Oct 5. Mutat Res. 2009. PMID: 18952194 Review.
Cited by
-
Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes.Mol Neurobiol. 2024 Jun 10. doi: 10.1007/s12035-024-04260-y. Online ahead of print. Mol Neurobiol. 2024. PMID: 38856793 Review.
-
Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models.Acta Neuropathol Commun. 2024 Apr 4;12(1):52. doi: 10.1186/s40478-024-01748-5. Acta Neuropathol Commun. 2024. PMID: 38576010 Free PMC article. Review.
-
Silica Nanoparticles Decrease Glutamate Uptake in Blood-Brain Barrier Components.Neurotox Res. 2024 Mar 4;42(2):20. doi: 10.1007/s12640-024-00696-1. Neurotox Res. 2024. PMID: 38436780 Free PMC article.
-
Dietary and Environmental Risk Factors in Parkinson's Disease and Alzheimer's Disease: Beware of Your Food Plate and Your Surroundings!Ann Indian Acad Neurol. 2023 Mar-Apr;26(2):101-103. doi: 10.4103/aian.aian_82_23. Epub 2023 Mar 17. Ann Indian Acad Neurol. 2023. PMID: 37179674 Free PMC article. No abstract available.
-
AD-Syn-Net: systematic identification of Alzheimer's disease-associated mutation and co-mutation vulnerabilities via deep learning.Brief Bioinform. 2023 Mar 19;24(2):bbad030. doi: 10.1093/bib/bbad030. Brief Bioinform. 2023. PMID: 36752347 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical